PRESS RELEASE

PRESS RELEASE

View printer-friendly version << Back

Novavax to Host Conference Call to Discuss Second Quarter 2017 Financial Results on August 8, 2017

Novavax to Host Conference Call to Discuss Second Quarter 2017 Financial Results on August 8, 2017

Gaithersburg, MD, August 1, 2017 -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday, August 8, 2017.

Conference call details are as follows:

Date:                           Tuesday, August 8, 2017
Time:                           4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:           (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:                    15614203
Webcast:                     www.novavax.com, “Investors”/ “Events”

Conference call and webcast replay:

Dates:                          Starts at 7:30 p.m. ET, August 8, 2017 until 7:30 pm ET, August 15, 2017
Dial-in number:           (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:                    15614203
Webcast:                     www.novavax.com, “Investors”/ “Events”, until November 8, 2017

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:         

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor Relations
ir@novavax.com 
240-268-2000

Westwicke Partners
John Woolford

 

john.woolford@westwicke.com
443-213-0506

Media
Russo Partners, LLC

 

David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271